Patents Assigned to Fapon Biotech Inc.
  • Patent number: 12291564
    Abstract: Provided is an isolated binding protein including an antigen-binding domain that binds to NS1 protein. The isolated binding protein includes specific heavy chain CDRs and light chain CDRs. The binding protein can specifically recognize and bind to NS1, and has relatively high sensitivity and specificity, thereby achieving the detection of dengue virus. Moreover, the binding protein is not required to be produced by inducing hybridoma cells in mouse abdominal cavity, and thus it is simple in production and has more stable antibody function.
    Type: Grant
    Filed: August 26, 2019
    Date of Patent: May 6, 2025
    Assignee: FAPON BIOTECH INC.
    Inventors: Peng Cui, Zhiqiang He, Yuan Meng, Dongmei Zhong
  • Patent number: 12281157
    Abstract: Provided is an isolated binding protein including an antigen binding domain binding to an NS1 protein, and including specific heavy chain CDR and light chain CDR. The binding protein can specifically identify and bind to NS1, and has relatively high sensitivity and specificity, so as to detect dengue vims. Moreover, the binding protein does not need to be produced by injecting hybridoma cells into mouse peritoneal cavity, while simplifying production, thus stabilizing antibody functionality.
    Type: Grant
    Filed: August 26, 2019
    Date of Patent: April 22, 2025
    Assignee: Fapon Biotech Inc.
    Inventors: Peng Cui, Zhiqiang He, Yuan Meng, Dongmei Zhong
  • Patent number: 12173056
    Abstract: Disclosed is an isolated binding protein including a cardiac troponin I (cTnI) antigen binding domain, and preparation and a use and the like of the binding protein. The antigen binding domain includes at least one complementarity determining region selected from an amino acid sequence defined in this article, or has at least 80% sequence identity with the complementarity determining region of the amino acid sequence and has KD?9.96×10?8 mol/L affinity with cTnI. The binding protein may be used in the detection field of the cTnI protein.
    Type: Grant
    Filed: September 27, 2019
    Date of Patent: December 24, 2024
    Assignee: FAPON BIOTECH INC.
    Inventors: Peng Cui, Zhiqiang He, Yuan Meng, Dongmei Zhong
  • Patent number: 12158469
    Abstract: The present disclosure relates to the field of medical diagnosis, and specifically, relates to a synthetic peptide for detecting HIV-1. The synthetic peptide is obtained by mutating the amino acid sequence set forth as SEQ ID NO: 1. The synthetic peptide can better detect anti-HIV-1 antibodies, and can better avoid potential “false negative” and “false positive” results.
    Type: Grant
    Filed: August 6, 2019
    Date of Patent: December 3, 2024
    Assignee: Fapon Biotech Inc.
    Inventors: Peng Cui, Zhiqiang He, Yuan Meng
  • Publication number: 20210172951
    Abstract: The present disclosure relates to the field of medical diagnosis, and specifically, relates to a synthetic peptide for detecting HIV-1. The synthetic peptide is obtained by mutating the amino acid sequence set forth as SEQ ID NO: 1. The synthetic peptide can better detect anti-HIV-1 antibodies, and can better avoid potential “false negative” and “false positive” results.
    Type: Application
    Filed: August 6, 2019
    Publication date: June 10, 2021
    Applicant: Fapon Biotech Inc.
    Inventors: Peng Cui, Zhiqiang He, Yuan Meng